04:21 PM EDT, 08/29/2025 (MT Newswires) -- Cedric Francois, Director, Chief Executive Officer, on August 27, 2025, sold 225,000 shares in Apellis Pharmaceuticals ( APLS ) for $6,352,743. Following the Form 4 filing with the SEC, Francois has control over a total of 1,646,027 common shares of the company, with 331,605 shares held directly and 1,314,422 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1492422/000119312525192797/xslF345X05/ownership.xml